The podocyte's response to stress: the enigma of foot process effacement.

Progressive loss of podocytes is the most frequent cause accounting for end-stage renal failure. Podocytes are complex, terminally differentiated cells incapable of replicating. Thus lost podocytes cannot be replaced by proliferation of neighboring undamaged cells. Moreover, podocytes occupy a unique position as epithelial cells, adhering to the glomerular basement membrane (GBM) only by their processes, whereas their cell bodies float within the filtrate in Bowman's space. This exposes podocytes to the danger of being lost by detachment as viable cells from the GBM. Indeed, podocytes are continually excreted as viable cells in the urine, and the rate of excretion dramatically increases in glomerular diseases. Given this situation, it is likely that evolution has developed particular mechanisms whereby podocytes resist cell detachment. Podocytes respond to stress and injury by undergoing tremendous changes in shape. Foot process effacement is the most prominent and, yet in some ways, the most enigmatic of those changes. This review summarizes the various structural responses of podocytes to injury, focusing on foot process effacement and detachment. We raise the hypothesis that foot process effacement represents a protective response of podocytes to escape detachment from the GBM.

[1]  S. Richard,et al.  Von Hippel-Lindau: how a rare disease illuminates cancer biology. , 2013, Seminars in cancer biology.

[2]  Xiwu Chen,et al.  Integrins in renal development , 2012, Pediatric Nephrology.

[3]  J. Brugarolas,et al.  State of the Science: An Update on Renal Cell Carcinoma , 2012, Molecular Cancer Research.

[4]  R. Ummanni,et al.  Morphology and migration of podocytes are affected by CD151 levels. , 2012, American journal of physiology. Renal physiology.

[5]  R. Schrier,et al.  Glomerular hyperfiltration: definitions, mechanisms and clinical implications , 2012, Nature Reviews Nephrology.

[6]  P. Mundel,et al.  Cell biology and pathology of podocytes. , 2012, Annual review of physiology.

[7]  T. Curran,et al.  Crk1/2-dependent signaling is necessary for podocyte foot process spreading in mouse models of glomerular disease. , 2012, The Journal of clinical investigation.

[8]  A. Sonnenberg,et al.  Blood pressure influences end-stage renal disease of Cd151 knockout mice. , 2012, The Journal of clinical investigation.

[9]  H. Anders,et al.  Tumour necrosis factor‐α drives Alport glomerulosclerosis in mice by promoting podocyte apoptosis , 2012, The Journal of pathology.

[10]  S. Kinugasa,et al.  Selective albuminuria via podocyte albumin transport in puromycin nephrotic rats is attenuated by an inhibitor of NADPH oxidase. , 2011, Kidney international.

[11]  S. Germain,et al.  Erratum: Epidermal growth factor receptor promotes glomerular injury and renal failure in rapidly progressive crescentic glomerulonephritis , 2011, Nature Medicine.

[12]  T. Reinheckel,et al.  CD2AP in mouse and human podocytes controls a proteolytic program that regulates cytoskeletal structure and cellular survival. , 2011, The Journal of clinical investigation.

[13]  A. Howie Problems with 'focal segmental glomerulosclerosis' , 2011, Pediatric Nephrology.

[14]  Richard J. Johnson,et al.  Minimal change disease: a CD80 podocytopathy? , 2011, Seminars in nephrology.

[15]  R. Nelson,et al.  Podocyte Detachment in Type 2 Diabetic Nephropathy , 2011, American Journal of Nephrology.

[16]  Hyun Soon Lee Mechanisms and consequences of TGF-ß overexpression by podocytes in progressive podocyte disease , 2011, Cell and Tissue Research.

[17]  C. Rivard,et al.  Minimal change disease: a “two-hit” podocyte immune disorder? , 2011, Pediatric Nephrology.

[18]  J. Kreidberg,et al.  Dystroglycan does not contribute significantly to kidney development or function, in health or after injury. , 2011, American journal of physiology. Renal physiology.

[19]  M. Schiffer,et al.  The role of metabolic and haemodynamic factors in podocyte injury in diabetes , 2011, Diabetes/metabolism research and reviews.

[20]  M. Schiffer,et al.  PKCα Mediates β-Arrestin2-dependent Nephrin Endocytosis in Hyperglycemia* , 2011, The Journal of Biological Chemistry.

[21]  A. Makris,et al.  Preeclamptic nephropathy , 2011, Nephrology.

[22]  T. Weide,et al.  Implications of autophagy for glomerular aging and disease , 2011, Cell and Tissue Research.

[23]  J. Peti-Peterdi,et al.  A high-powered view of the filtration barrier. , 2010, Journal of the American Society of Nephrology : JASN.

[24]  P. Romagnani,et al.  Glomerular epithelial stem cells: the good, the bad, and the ugly. , 2010, Journal of the American Society of Nephrology : JASN.

[25]  M. Hara,et al.  Podocyte membrane vesicles in urine originate from tip vesiculation of podocyte microvilli. , 2010, Human pathology.

[26]  S. Hatakeyama,et al.  Inhibition of podocyte FAK protects against proteinuria and foot process effacement. , 2010, Journal of the American Society of Nephrology : JASN.

[27]  Mark L. Johnson,et al.  Prostaglandin E2 is crucial in the response of podocytes to fluid flow shear stress , 2010, Journal of Cell Communication and Signaling.

[28]  L. Gnudi,et al.  Mechanical forces and TGFbeta1 reduce podocyte adhesion through alpha3beta1 integrin downregulation. , 2009, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[29]  M. Nagata,et al.  Acute and Transient Podocyte Loss and Proteinuria in Preeclampsia , 2009, Nephron Clinical Practice.

[30]  B. Smeets,et al.  Recruitment of podocytes from glomerular parietal epithelial cells. , 2009, Journal of the American Society of Nephrology : JASN.

[31]  R. Maas,et al.  Rapid development of severe end-organ damage in C57BL/6 mice by combining DOCA salt and angiotensin II. , 2008, Kidney international.

[32]  S. Karumanchi,et al.  The glomerular injury of preeclampsia. , 2007, Journal of the American Society of Nephrology : JASN.

[33]  E. Bottinger TGF-β in renal injury and disease , 2007 .

[34]  H. Haller,et al.  CD2AP/CIN85 Balance Determines Receptor Tyrosine Kinase Signaling Response in Podocytes* , 2007, Journal of Biological Chemistry.

[35]  M. Hara,et al.  Cumulative excretion of urinary podocytes reflects disease progression in IgA nephropathy and Schönlein-Henoch purpura nephritis. , 2007, Clinical journal of the American Society of Nephrology : CJASN.

[36]  K. Endlich,et al.  Podocytes are sensitive to fluid shear stress in vitro. , 2006, American journal of physiology. Renal physiology.

[37]  P. Gerke,et al.  β-Arrestin2 mediates nephrin endocytosis and impairs slit diaphragm integrity , 2006, Proceedings of the National Academy of Sciences.

[38]  M. Kretzler,et al.  Integrin-linked kinase in renal disease: connecting cell–matrix interaction to the cytoskeleton , 2005, Current opinion in nephrology and hypertension.

[39]  S. Shankland,et al.  Urinary podocyte loss is a more specific marker of ongoing glomerular damage than proteinuria. , 2005, Journal of the American Society of Nephrology : JASN.

[40]  Thomas Benzing,et al.  The slit diaphragm: a signaling platform to regulate podocyte function , 2005, Current opinion in nephrology and hypertension.

[41]  S. Harper,et al.  Three-dimensional reconstruction of glomeruli by electron microscopy reveals a distinct restrictive urinary subpodocyte space. , 2005, Journal of the American Society of Nephrology : JASN.

[42]  S. Shankland,et al.  Viable Podocytes Detach in Experimental Diabetic Nephropathy: Potential Mechanism Underlying Glomerulosclerosis , 2004, Nephron Experimental Nephrology.

[43]  J. G. van den Berg,et al.  Podocyte foot process effacement is not correlated with the level of proteinuria in human glomerulopathies. , 2004, Kidney international.

[44]  K. Endlich,et al.  Alterations of podocytes in a murine model of crescentic glomerulonephritis , 2004, Histochemistry and Cell Biology.

[45]  R. Bilous,et al.  Structural alterations to the podocyte are related to proteinuria in type 2 diabetic patients. , 2004, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[46]  R. Kalluri,et al.  Induction of B7-1 in podocytes is associated with nephrotic syndrome. , 2004, The Journal of clinical investigation.

[47]  R. Siegel,et al.  Measurement of Apoptosis and Other Forms of Cell Death , 2004, Current protocols in immunology.

[48]  B. Yard,et al.  SCG/Kinjoh mice: a model of ANCA-associated crescentic glomerulonephritis with immune deposits. , 2003, Kidney international.

[49]  K. Lemley,et al.  Urinary excretion of viable podocytes in health and renal disease. , 2003, American journal of physiology. Renal physiology.

[50]  N. Gretz,et al.  Pathways to recovery and loss of nephrons in anti-Thy-1 nephritis. , 2003, Journal of the American Society of Nephrology : JASN.

[51]  Michiko Watanabe,et al.  The Pros and Cons of Apoptosis Assays for Use in the Study of Cells, Tissues, and Organs , 2002, Microscopy and Microanalysis.

[52]  W. Wurst,et al.  Nephrin TRAP mice lack slit diaphragms and show fibrotic glomeruli and cystic tubular lesions. , 2002, Journal of the American Society of Nephrology : JASN.

[53]  I. Shirato Podocyte process effacement in vivo , 2002, Microscopy research and technique.

[54]  Kevin V Lemley,et al.  Podocytopenia and disease severity in IgA nephropathy. , 2002, Kidney international.

[55]  M. Hara,et al.  Significance of urinary binucleated podocytes in IgA nephropathy , 2001 .

[56]  M. Le Hir,et al.  Podocyte bridges between the tuft and Bowman's capsule: an early event in experimental crescentic glomerulonephritis. , 2001, Journal of the American Society of Nephrology : JASN.

[57]  E. Bottinger,et al.  Apoptosis in podocytes induced by TGF-β and Smad7 , 2001 .

[58]  T. Graf,et al.  Anuria, Omphalocele, and Perinatal Lethality in Mice Lacking the Cd34-Related Protein Podocalyxin , 2001, The Journal of experimental medicine.

[59]  N. Gretz,et al.  Podocyte injury underlies the progression of focal segmental glomerulosclerosis in the fa/fa Zucker rat. , 2001, Kidney international.

[60]  D. Uttenweiler,et al.  Podocytes respond to mechanical stress in vitro. , 2001, Journal of the American Society of Nephrology : JASN.

[61]  Shyi-Jang Shin,et al.  Altering expression of α3β1 integrin on podocytes of human and rats with diabetes , 2000 .

[62]  I. Ebihara,et al.  Effects of Angiotensin-Converting Enzyme Inhibitor, Angiotensin II Receptor Antagonist and Calcium Antagonist on Urinary Podocytes in Patients with IgA Nephropathy , 2000, American Journal of Nephrology.

[63]  T. Nakamura,et al.  Urinary excretion of podocytes in patients with diabetic nephropathy. , 2000, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[64]  I. Ebihara,et al.  Urinary Podocytes for the Assessment of Disease Activity in Lupus Nephritis , 2000, The American journal of the medical sciences.

[65]  H. Kawachi,et al.  Severe proteinuria, sustained for 6 months, induces tubular epithelial cell injury and cell infiltration in rats but not progressive interstitial fibrosis. , 2000, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[66]  D. Salant,et al.  Complement-mediated injury reversibly disrupts glomerular epithelial cell actin microfilaments and focal adhesions. , 1999, Kidney international.

[67]  N. Gretz,et al.  Progression of glomerular diseases: is the podocyte the culprit? , 1998, Kidney international.

[68]  J. L. Simons,et al.  Development of vascular pole-associated glomerulosclerosis in the Fawn-hooded rat. , 1998, Journal of the American Society of Nephrology : JASN.

[69]  Tadashi Yamamoto,et al.  Urinary Excretion of Podocytes Reflects Disease Activity in Children with Glomerulonephritis , 1998, American Journal of Nephrology.

[70]  T. Yamamoto,et al.  Podocyte detachment and epithelial cell reaction in focal segmental glomerulosclerosis with cellular variants. , 1997, Kidney international. Supplement.

[71]  M. Welsh,et al.  Podocyte alpha-actinin induction precedes foot process effacement in experimental nephrotic syndrome. , 1997, The American journal of physiology.

[72]  G. Remuzzi,et al.  Renal and systemic nitric oxide synthesis in rats with renal mass reduction. , 1997, Kidney international.

[73]  Y. Tomino,et al.  The development of focal segmental glomerulosclerosis in Masugi nephritis is based on progressive podocyte damage , 1996, Virchows Archiv.

[74]  Kenjiro,et al.  Cytoskeletal changes in podocytes associated with foot process effacement in Masugi nephritis. , 1996, The American journal of pathology.

[75]  W. Kriz,et al.  Long-term treatment of rats with FGF-2 results in focal segmental glomerulosclerosis. , 1995, Kidney international.

[76]  F. Gudat,et al.  Podocytes loose their adhesive phenotype in focal segmental glomerulosclerosis. , 1995, Clinical nephrology.

[77]  K. Schärer,et al.  Glomerular damage after uninephrectomy in young rats. I. Hypertrophy and distortion of capillary architecture. , 1992, Kidney international.

[78]  M. Nagata,et al.  Glomerular damage after uninephrectomy in young rats. II. Mechanical stress on podocytes as a pathway to sclerosis. , 1992, Kidney international.

[79]  T. Meyer,et al.  Glomerular hypertrophy and epithelial cell injury modulate progressive glomerulosclerosis in the rat. , 1989, Laboratory investigation; a journal of technical methods and pathology.

[80]  T. Oite,et al.  Massive proteinuria induced in rats by a single intravenous injection of a monoclonal antibody. , 1988, Journal of immunology.

[81]  B. Chavers,et al.  Observations of glomerular epithelial cell structure in patients with type I diabetes mellitus. , 1987, Kidney international.

[82]  B. Brenner,et al.  Altered glomerular permselectivity and progressive sclerosis following extreme ablation of renal mass. , 1982, Kidney international.

[83]  A. B. Maunsbach,et al.  Quantitative relationship between glomerular foot process width and proteinuria in glomerulonephritis. , 1981, Laboratory investigation; a journal of technical methods and pathology.

[84]  M. Karnovsky,et al.  An ultrastructural study of the mechanisms of proteinuria in aminonucleoside nephrosis. , 1975, Kidney international.

[85]  J. Churg,et al.  Focal glomerular sclerosis in nephrotic patients: an electron microscopic study of glomerular podocytes. , 1975, Kidney international.

[86]  R. Shalhoub Pathogenesis of lipoid nephrosis: a disorder of T-cell function. , 1974, Lancet.

[87]  K. Shedden,et al.  Angiotensin II-dependent persistent podocyte loss from destabilized glomeruli causes progression of end stage kidney disease. , 2012, Kidney international.

[88]  K. Endlich,et al.  (cid:1) V -Integrins mediate the mechanoprotective action of osteopontin in podocytes , 2010 .

[89]  L. Gnudi,et al.  Mechanical forces and TGF β 1 reduce podocyte adhesion through α 3 β 1 integrin downregulation , 2009 .

[90]  E. Böttinger TGF-beta in renal injury and disease. , 2007, Seminars in nephrology.

[91]  H. Haller,et al.  SaO022 GLYCATED ALBUMIN IS A BETTER GLYCEMIC INDICATOR THAN GLYCATED HEMOGLOBIN VALUES IN DIABETIC HEMODIALYSIS PATIENTS; EFFECT OF ANEMIA AND ERYTHROPOIETIN INJECTION Scientific techniques for probing renal disease SaO023 CD2AP/CIN85 BALANCE DETERMINES RTK-SIGNALING RESPONSE IN PODOCYTES , 2007 .

[92]  M. Kretzler,et al.  Podocyte damage is a critical step in the development of glomerulosclerosis in the uninephrectomised-desoxycorticosterone hypertensive rat , 2004, Virchows Archiv.

[93]  Matthias Kretzler,et al.  Cell biology of the glomerular podocyte. , 2003, Physiological reviews.

[94]  K. Tryggvason,et al.  The murine nephrin gene is specifically expressed in kidney, brain and pancreas: inactivation of the gene leads to massive proteinuria and neonatal death. , 2001, Human molecular genetics.

[95]  M. Bitzer,et al.  Apoptosis in podocytes induced by TGF-beta and Smad7. , 2001, The Journal of clinical investigation.

[96]  M. Regoli,et al.  Alterations in the expression of the a3b1 integrin in certain membrane domains of the glomerular epithelial cells (podocytes) in diabetes mellitus , 1997, Diabetologia.

[97]  P. Klok,et al.  Minimal change-like glomerular alterations induced by a human plasma factor. , 1996, Nephron.

[98]  Y. Komatsu,et al.  Mitosis and the presence of binucleate cells among glomerular podocytes in diseased human kidneys. , 1995, Nephron.

[99]  K. Kawasaki,et al.  Urinary excretion of podocalyxin indicates glomerular epithelial cell injuries in glomerulonephritis. , 1995, Nephron.

[100]  R. Cotran,et al.  Pathogenesis of polycation-induced alterations ("fusion") of glomerular epithelium. , 1977, Laboratory investigation; a journal of technical methods and pathology.

[101]  M. Farquhar,et al.  Alterations of the glomerular epithelium in acute aminonucleoside nephrosis. Evidence for formation of occluding junctions and epithelial cell detachment. , 1976, Laboratory investigation; a journal of technical methods and pathology.

[102]  R. Cotran,et al.  ULTRASTRUCTURAL STUDIES IN EXPE)t~NTAL NEPHROSIS USING HORSERADISH PEROXIDASE AS A TRACER* , 1969 .

[103]  N. Gretz,et al.  J Am Soc Nephrol 15: 1475–1487, 2004 Angiotensin II Type 1 Receptor Overexpression in Podocytes Induces Glomerulosclerosis in Transgenic Rats , 2022 .